文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

每日呼吸治疗师评估静脉-静脉体外膜氧合撤离准备情况在急性呼吸窘迫综合征患者中的应用

A Daily, Respiratory Therapist Assessment of Readiness to Liberate From Venovenous Extracorporeal Membrane Oxygenation in Patients With Acute Respiratory Distress Syndrome.
PubMed 文献 · Crit Care Explor · 2021-12-03
一句话结论单中心回顾性研究显示,每日由呼吸治疗师按预设标准评估静脉-静脉体外膜氧合撤离准备,与首次扫气关闭试验更早、体外膜氧合时长更短相关。

该单中心回顾性前后对照研究纳入2013至2019年接受静脉-静脉体外膜氧合治疗的急性呼吸窘迫综合征患者180例,2016年起实施每日由呼吸治疗师评估扫气关闭试验准备情况的方案。实施前67例、实施后113例;实施后组体外膜氧合时长(5.5天 vs 11天,p<0.001)、首次扫气关闭试验时间(2.5天 vs 7.0天,p<0.001)、机械通气时长(15.0天 vs 25天,p=0.017)及ICU住院时间(18天 vs 27.0天,p=0.008)均缩短;住院时间及出院生存率无差异。

要点

  • 实施每日呼吸治疗师评估撤离准备方案后,体外膜氧合时长由11天(7-15.5天)缩短至5.5天(3-11天),p<0.001。
  • 首次扫气关闭试验时间由7.0天(5-11天)提前至2.5天(1-5天),p<0.001。
  • 机械通气时长由25天(21-33天)缩短至15.0天(9-31天),p=0.017。
  • ICU住院时间由27.0天(21-36天)缩短至18天(10-33天),p=0.008。
  • 住院时间及出院生存率在实施前后无观察到的差异。

适用人群与场景

  • 2013至2019年在单中心学术医学中心内科ICU接受静脉-静脉体外膜氧合治疗的急性呼吸窘迫综合征患者180例。
  • 实施前组67例,实施后组113例。

诊断标准与关键阈值

  • 当患者符合预设标准时,由呼吸治疗师执行扫气关闭试验以判断是否具备停止静脉-静脉体外膜氧合的条件。

处置流程与药物剂量

  • 2016年起实施每日评估静脉-静脉体外膜氧合扫气关闭试验准备情况。
  • 患者符合预设标准后,由呼吸治疗师执行扫气关闭试验,以确定是否可停止静脉-静脉体外膜氧合。

研究设计与关键结果

  • 单中心回顾性前后对照研究,纳入2013至2019年接受静脉-静脉体外膜氧合治疗的急性呼吸窘迫综合征患者180例(实施前67例,实施后113例)。
  • 实施后组体外膜氧合时长5.5天(3-11天)vs 实施前组11天(7-15.5天),p<0.001。
  • 实施后组首次扫气关闭试验时间2.5天(1-5天)vs 实施前组7.0天(5-11天),p<0.001。
  • 实施后组机械通气时长15.0天(9-31天)vs 实施前组25天(21-33天),p=0.017。
  • 实施后组ICU住院时间18天(10-33天)vs 实施前组27.0天(21-36天),p=0.008。
  • 住院时间及出院生存率在实施前后无观察到的差异。
  • 作者结论:在存活者中,实施后组机械通气时长和ICU住院时间缩短,住院时间或住院死亡率无观察到的差异。

证据类型、等级与局限

  • 证据类型:单中心回顾性前后对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 本研究提示,在急性呼吸窘迫综合征接受静脉-静脉体外膜氧合治疗的患者中,每日由呼吸治疗师按预设标准评估扫气关闭试验准备情况,与首次扫气关闭试验更早及体外膜氧合时长更短相关。
  • 作者指出,在存活者中实施后组机械通气时长和ICU住院时间缩短,住院时间或住院死亡率无观察到的差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: We assessed the effect of implementing a protocol-directed strategy to determine when patients can be liberated from venovenous extracorporeal membrane oxygenation on extracorporeal membrane oxygenation duration, time to initiation of first sweep-off trial, duration of mechanical ventilation, ICU length of stay, hospital length of stay, and survival to hospital discharge.

DESIGN: Single-center retrospective before and after study.

SETTING: The medical ICU at an academic medical center.

PATIENTS: One-hundred eighty patients with acute respiratory distress syndrome managed with venovenous extracorporeal membrane oxygenation at a single institution from 2013 to 2019.

INTERVENTIONS: In 2016, our institution implemented a daily assessment of readiness for a trial off extracorporeal membrane oxygenation sweep gas ("sweep-off trial"). When patients met prespecified criteria, the respiratory therapist performed a sweep-off trial to determine readiness for discontinuation of venovenous extracorporeal membrane oxygenation.

MEASUREMENTS AND MAIN RESULTS: Sixty-seven patients were treated before implementation of the sweep-off trial protocol, and 113 patients were treated after implementation. Patients managed using the sweep-off trial protocol had a significantly shorter extracorporeal membrane oxygenation duration (5.5 d [3-11 d] vs 11 d [7-15.5 d]; p < 0.001), time to first sweep-off trial (2.5 d [1-5 d] vs 7.0 d [5-11 d]; p < 0.001), duration of mechanical ventilation (15.0 d [9-31 d] vs 25 d [21-33 d]; p = 0.017), and ICU length of stay (18 d [10-33 d] vs 27.0 d [21-36 d]; p = 0.008). There were no observed differences in hospital length of stay or survival to hospital discharge.

CONCLUSIONS: In patients with acute respiratory distress syndrome managed with venovenous extracorporeal membrane oxygenation at our institution, implementation of a daily, respiratory therapist assessment of readiness for a sweep-off trial was associated with a shorter time to first sweep-off trial and shorter duration of extracorporeal membrane oxygenation. Among survivors, the postassessment group had a reduced duration of mechanical ventilation and ICU lengths of stay. There were no observed differences in hospital length of stay or inhospital mortality.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Pratt EH, Mausert S, Wilson MD, et al. A Daily, Respiratory Therapist Assessment of Readiness to Liberate From Venovenous Extracorporeal Membrane Oxygenation in Patients With Acute Respiratory Distress Syndrome. Crit Care Explor. 2021. PMID: 34881366. doi:10.1097/CCE.0000000000000584

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。